ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 91 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $36,000 | +200.0% | 17,025 | +221.8% | 0.00% | +200.0% |
| Q2 2018 | $12,000 | – | 5,291 | +6597.5% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 79 | -98.5% | 0.00% | -100.0% |
| Q3 2017 | $24,000 | -36.8% | 5,250 | -54.3% | 0.00% | -50.0% |
| Q2 2017 | $38,000 | +22.6% | 11,490 | +238.8% | 0.00% | +33.3% |
| Q1 2017 | $31,000 | +3000.0% | 3,391 | +3129.5% | 0.00% | – |
| Q4 2016 | $1,000 | -95.8% | 105 | -95.0% | 0.00% | -100.0% |
| Q3 2016 | $24,000 | +84.6% | 2,112 | +103.7% | 0.00% | +100.0% |
| Q2 2016 | $13,000 | 0.0% | 1,037 | -19.0% | 0.00% | -50.0% |
| Q1 2016 | $13,000 | +85.7% | 1,280 | +316.9% | 0.00% | +100.0% |
| Q4 2015 | $7,000 | -77.4% | 307 | -77.8% | 0.00% | -66.7% |
| Q2 2015 | $31,000 | +34.8% | 1,382 | +54.9% | 0.00% | 0.0% |
| Q1 2015 | $23,000 | – | 892 | +4360.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 20 | -99.5% | 0.00% | -100.0% |
| Q4 2013 | $121,000 | +3933.3% | 4,102 | +1951.0% | 0.02% | – |
| Q3 2013 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|